HuiKai Li

2 clinical trials · Sponsor

Record	Firm	Date
Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II (NCT07649980)	HuiKai Li	2026-07-01
Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy (NCT05975463)	HuiKai Li	2023-09-15

Every clearance here is in the API, with alerts when new ones post.